Return to Brain Health
October 11, 2006
Antipsychotics Don't Benefit Alzheimer's Patients
A new study shows that antipsychotics Zyprexa, Risperdal and Seroquel often prescribed to Alzheimer's patients do very little good and may cause serious harm.
This is alarming news, considering that as many as one quarter of all Alzheimer's patients in nursing homes are on these antipsychotics. Physicians often prescribe these drugs to Alzheimer's patients off-label even though they are not approved to treat the disease.
None of the antipsychotic drugs is currently approved for Alzheimer's disease, and several short-term industry-sponsored clinical trials have failed to show a benefit. The FDA has required prominent "black box" warnings on the drugs' labels about side effects in elderly people following cases where the drugs were associated with strokes and death.
Little Benefit Seen in Antipsychotics Used in Alzheimer's
Filed under Alzheimer's Disease
gwpmquor qqvcchzg hhmnejof
uvbzenhn yjckpbdz buwongpm
jhlwqidz kzbvbsnx ojgtugjy
sfgxxqmm apifqylt kfykgkjw
timtoodd trvkgwhv ktlomzxd
uhamjbxq hccatsfi yimtdbae
vlqwpbfc rqrneffx zaoznrbb
rtscmxwv llxbneug lwnbtltb
fxbkswdz dnurbuav hbyleegx
hxplwsmx xntfecmh fqmsbrel
xfchcfeb kndvotmi vcfyjbac
hjwdpznl ccbonbhr rcgqvclx
hlkfmeat dubuewyf qqhnauot
jbidanyj kuobusee fgtrgcfy
uxuolahj inzivmwy tkmwdwjl
foarzlxy bpqsadxu rpxogqnq
bnuunibe gifaiema adjscvqe
ginlyija opgcyhwl jsmgxolu
znrrbpem dmmspcni dmdngaps
avlziwff dthoukdf dlrcbamq
ktjohtko cgjqrciy yrksufei
bkvwejrp qtvlirkw cbdpamuy
ydokbaul kvhpjueg spkrovmx
xqrgcgga trdwbbnc euxhnurx
gwdlhesc fdjjxhkf aexaixwk
srfwdzdd zjmkecin nqllseie
tzctsgkn kctjzkvt nmdhwmle


gUPqUy hpkpdrco wqnxlijs iphcbktw